|
|
|
|
|
Legal status
Application deemed to be withdrawn
| (51) | INT.CL.: (2006.01) |
A61K 38/21 A61P 19/00 A61P 25/00 A61P 29/00 A61P 31/00 A61P 35/00 A61P 37/00 A61P 43/00 C07K 14/435 A61K 38/00 |
| (11) | Number of the document | |
| (13) | Kind of document | A |
| (21) | Application number | 2002 123 |
| (22) | Date of filing the application | 2002-12-02 |
| (41) | Date of publication of the application | 2003-06-25 |
| (45) | Date of publication of patent |
| (86) | Number | PCT/US01/41022 |
| Date | 2001-06-18 |
| (87) | Number | WO 01/95929 |
| Date | 2001-12-20 |
| (30) | Number | Date | Country code |
| 60/212,046 | 2000-06-16 | US | |
| 09/881,050 | 2001-06-15 | US |
| (71) |
SCHERING AKTIENGESELLSCHAFT,
13342 Berlin,
DE
|
| (72) |
Edward M. CROZE, US
Daryl FAULDS, US T. Charis WAGNER, US |
| (73) |
SCHERING AKTIENGESELLSCHAFT,
13342 Berlin,
DE
|
| (74) |
Rita LAURINAVIČIŪTĖ,
Gedimino pr. 45-6, LT-01109 Vilnius,
LT
|
| (54) | NOVEL INTERFERON FOR THE TREATMENT OF MULTIPLE SCLEROSIS |